Compare ARK Genomic Revolution ETF (ARKG) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Rocket Lab USA Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.23, while Rocket Lab USA Inc trades at $77.8 (market cap $50.64B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Rocket Lab USA Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | RKLB | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $150.23 |
52-Week Low | $23.09 | $39.03 |
Market Cap | — | $50.64B |
Enterprise Value | — | $49.39B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Rocket Lab (RKLB) trades at $81.04, down 1.83% amid broader space sector weakness. The stock shows bearish technical signals with support at $77-$81 levels, while fundamentals reveal strong revenue growth ($602M in 2025) but persistent losses (-$198M net income). Recent news highlights the $8B Iridium acquisition and innovative 'Hungry Hippo' technology, positioning the company for long-term growth in the expanding space economy.
Analyst consensus remains bullish with a $119.10 price target (75% buy ratings), though profitability challenges and high valuations (P/S 66.26) present near-term risks. The company's expansion into satellite communications and defense contracts provides growth catalysts, but investors face volatility from sector-wide valuation concerns and execution risks on major acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
